Bionano Genomics- Warrants (21/08/2023) Total Current Liabilities

As of the most recent data (March 2026), BNGOW shows a total current liabilities of $21M. That compares with $26M in the prior-year period — down 19.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BNGOW's total current liabilities is now $21M (was $26M) — a 19.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bionano Genomics- Warrants (21/08/2023) is outperforming or lagging.

Tracking BNGOW's total current liabilities over time shows whether Bionano Genomics- Warrants (21/08/2023) is scaling, shrinking, or reshaping that part of the business. The current reading is $21M That compares with $26M in the prior-year period — down 19.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Bionano Genomics- Warrants (21/08/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $21M) with ownership activity and broader fundamentals.

Bionano Genomics- Warrants (21/08/2023)'s total current liabilities is $21M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.